Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Optimal Responders: A Benefit Population Atlas of Neoadjuvant Immunochemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer

NCT07098104 is registered in ClinicalTrials.gov with Cheng Chen as lead sponsor.

NCT NCT07098104
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07098104 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Optimal Responders: A Benefit Population Atlas of Neoadjuvant Immunochemotherapy Versus Chemotherapy for Locally Advanced Gastric Cancer
Lead sponsor
Cheng Chen
Phase
Observational
Overall status
Completed
Start date
November 1, 2019
Completion date
May 1, 2025
Enrollment
291 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

gastric cancer